Development and Validation of a Simplified Financial Toxicity Screening Tool for Use in Clinical Practice
This analysis of a large data set finds that a simplified COST tool has high predictive value when compared with the full validated measure. An abbreviated COST measure of two questions is suitable for implementation into clinical screening workflows.
Authors
- Fumiko Chino (ORCID: https://orcid.org/0000-0003-0498-488X)
- Andrew Julian Vickers (ORCID: https://orcid.org/0000-0003-1525-6503)
- Amy L. Tin (ORCID: https://orcid.org/0000-0002-8005-0694)
- Emeline Aviki (ORCID: https://orcid.org/0000-0003-0891-9399)
- Bridgette Thom (ORCID: https://orcid.org/0000-0001-6239-1666)
Institutions
- University of North Carolina at Chapel Hill (US)
- Memorial Sloan Kettering Cancer Center (US)
- NYU Langone Health (US)
- NYU Langone’s Laura and Isaac Perlmutter Cancer Center
- UNC Lineberger Comprehensive Cancer Center
- New York University (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1200/op-24-00598
- Citations
- 14
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 43.84
Funders
- Memorial Sloan-Kettering Cancer Center
- National Institutes of Health
- National Cancer Institute